ngµç×ÓÓÎÏ·

03
Ê×Ò³ / ½Ìѧ¿ÆÑÐ / ÕýÎÄ

ngµç×ÓÓÎÏ·Ç®¾ü½ÌÊÚÍŶÓÕ¹ÏÖ°£²©À­²¡¶¾¡°ÓÅÊÆ¡±Í»±ä£¬ÎªÒßÇé·À¿ØÓëÒ©ÎïÑз¢Ìṩ¿ÆÑ§ÒÀ¾Ý

¸å¼þȪԴ£º¹«¹²ÎÀÉúѧԺ£¨ÉîÛÚ£© ±à¼­£ºÓàæÃ ÉóºË£ºËïÒ«±ó ÔĶÁÁ¿£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ºÎ¼ÎÃô)2026Äê1ÔÂ23ÈÕ£¬ngµç×ÓÓÎÏ·Ç®¾ü½ÌÊÚÍŶÓÁªºÏ¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôÊаËÒ½ÔºÁõÁÖÄȽÌÊÚÍŶÓ¡¢¡¢¡¢¼ªÁÖ´óѧµÚÒ»Ò½ÔºÁõÈ«½ÌÊÚÍŶÓÒÔ¼°ngµç×ÓÓÎÏ·ÑÈÙ½ÌÊÚÍŶÓ£¬ÔÚCellÉϽÒÏþÁËÌâΪ¡°Molecular characterization of Ebola virus glycoprotein V75A substitution in the 2018¨C2020 epidemic¡±µÄÑо¿ÂÛÎÄ¡£¡£¸ÃÑо¿Õ¹ÏÖÁË2018-2020Äê°£²©À­ÒßÇéÖзºÆðµÄÓÅÊÆÍ»±äGP-V75A£¬²¢ÆÊÎöÁ˸ÃÍ»±äÔöÇ¿²¡¶¾Ñ¬È¾ÐԵķÖ×Ó»úÖÆ¡£¡£

Ñо¿ÍŶӶÔ480ÌõEBOVÈ«»ùÒò×é¾ÙÐÐÆÊÎö£¬·¢Ã÷Я´øÌÇÂѰ×GP-V75AÍ»±äµÄ¶¾ÖêÔÚÒßÇéÔçÆÚ·ºÆð£¬Ö®ºóѸËÙÈ¡´úԭʼ¶¾Ö꣬ÆäÊ¢ÐÐÇ÷ÊÆÓ벡Àý¼¤Ôö¸ß¶ÈÖØºÏ£¬ÌáÐѸÃÍ»±ä¿ÉÄÜÌá¸ßÁ˲¡¶¾µÄÈö²¥ÓÅÊÆ¡£¡£ÎªÑéÖ¤ÆäÉúÎïѧЧӦ£¬ÍŶÓʹÓöàÖÖʵÑéÄ£×Ó¿ªÕ¹Ñо¿£¬Ð§¹ûÅú×¢¸ÃÍ»±äÄÜÏÔÖøÔöÇ¿EBOV¶Ô¶àÖÖËÞÖ÷ϸ°û¼°Ð¡ÊóµÄѬȾÄÜÁ¦¡£¡£»£»£»úÖÆÑо¿·¢Ã÷£¬¸ÃÍ»±äͨ¹ýÎȹÌÂѰ׹¹ÏóÔöÇ¿GPÓ벡¶¾ÊÜÌåNPC1µÄÁ¬Ïµ£¬Í¬Ê±½µµÍ²¡¶¾½øÈëϸ°ûʱ¶ÔËÞÖ÷×éÖ¯ÂѰ×øµÄÒÀÀµ¡£¡£±ðµÄ£¬Ñо¿»¹·¢Ã÷¸ÃÍ»±äÄܹ»Ï÷Èõ²¿·ÖÏÖÓÐÖÎÁÆÐÔ¿¹Ì弰С·Ö×Ó½øÈëÒÖÖÆ¼ÁµÄ¿¹²¡¶¾Ð§¹û£¬ÌáÐÑGP-V75AÍ»±ä¿ÉÄÜ´øÀ´ÄÍÒ©·çÏÕ¡£¡£

154C58448CAC4406690336B9DAA_EE032FFC_2F748


±¾Ñо¿²»µ«ÆÊÎöÁËGP-V75AÍ»±äÔÚEVDÒßÇéÈö²¥ÖеÄÒªº¦×÷Óã¬Ò²Í¹ÏÔÁËÔÚÖØ´óÒßÇéÖпªÕ¹ÊµÊ±²¡¶¾»ùÒò×é¼à²âµÄÖ÷ÒªÐÔ£¬²¢ÎªÎ´À´¿ª·¢¹ãÆ×¿¹EBOVÕ½ÂÔÌṩÁË¿ÆÑ§ÒÀ¾Ý¡£¡£

Ç®¾ü½ÌÊÚΪ×îºóͨѶ×÷Õߣ¬ÁõÁÖÄȽÌÊÚ¡¢¡¢¡¢ÁõÈ«½ÌÊÚºÍÑÈÙ½ÌÊÚΪÅäºÏͨѶ×÷Õß¡£¡£ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ£¨ÉîÛÚ£©²©Ê¿ºó·¶ÁÖ½ø¡¢¡¢¡¢¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôÊаËÒ½Ôº²©Ê¿ºóÍõÓêÁú¡¢¡¢¡¢ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ²©Ê¿ÉúÍõÓ¢ºÀΪÅäºÏµÚÒ»×÷Õß¡£¡£


ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1016/j.cell.2025.12.022


¡¾ÍøÕ¾µØÍ¼¡¿